Related Experiment Videos

Auxotrophy of Pseudomonas aeruginosa in cystic fibrosis

R F Taylor1, M E Hodson, T L Pitt

  • 1Royal Brompton and National Heart Hospital, London, UK.

Insights

Auxotrophy, a growth deficiency, is common in Pseudomonas aeruginosa infections in cystic fibrosis (CF) patients. This finding suggests a link between CF and P. aeruginosa auxotrophic mutations.

Area of Science:

  • Microbiology
  • Genetics
  • Pulmonology

Background:

  • Pseudomonas aeruginosa is an opportunistic pathogen frequently found in cystic fibrosis (CF) patients.
  • Auxotrophy, the inability to synthesize essential organic compounds, can impact bacterial fitness and virulence.

Purpose of the Study:

  • To investigate the prevalence of auxotrophic Pseudomonas aeruginosa strains in patients with cystic fibrosis.
  • To compare auxotrophy rates in P. aeruginosa from CF patients versus those with non-CF bronchiectasis and healthy individuals.

Main Methods:

  • Sputum isolates of P. aeruginosa were collected from adult patients with CF and non-CF bronchiectasis.
  • Bacterial strains were screened for auxotrophy (growth factor requirements).
  • Growth factor requirements for auxotrophic strains were identified.

Main Results:

  • 18.4% of P. aeruginosa isolates from CF patients were auxotrophic.
  • 18.2% of P. aeruginosa isolates from non-CF bronchiectasis patients were auxotrophic.
  • All P. aeruginosa strains from non-bronchiectatic sources were prototrophic (lacked growth factor requirements).
  • Methionine was the most common single growth factor required by CF auxotrophs.

Conclusions:

  • Auxotrophy is a significant characteristic of P. aeruginosa infections in cystic fibrosis.
  • The high prevalence of auxotrophy in CF suggests a potential role in disease progression or adaptation within the CF lung environment.

Related Concept Videos